🇫🇷 France Country × Condition
lymphoma Clinical Trials in France
Active clinical trials for lymphoma with research sites in France. All data sourced live from ClinicalTrials.gov — updated daily.
Active Trials: 4 // Recruiting: 4 // Updated: Daily
Total Trials
4
Recruiting Now
4
Country
🇫🇷 France
Active Trials in France (4)
NCT02595255
Recruiting
AMH as a Predictor of Infertility Risk in Children With Cancer (CHANCE)
Enrollment
275 pts
Country
🇫🇷 France
Erasme University Hospital
View Trial → NCT05223413
Recruiting
REmote iSchemic condItioning in Lymphoma PatIents REceiving ANthraCyclinEs
Enrollment
608 pts
Country
🇫🇷 France
Fundación Centro Nacional de Invest...
View Trial → NCT05388838
Recruiting
Screening for Oculocerebral Lymphoma with the Phenotype of NK Cells in Patients with Uveitis
Enrollment
60 pts
Country
🇫🇷 France
Hospices Civils de Lyon
View Trial → NCT06409767
Recruiting
Impact of an Early Warning System on the Prognosis of Patients With Hematological Malignancies Receiving Intensive Chemotherapy With or Without Hematopoietic Cell Transplantation.
Enrollment
2,224 pts
Country
🇫🇷 France
University Hospital, Angers
View Trial → Frequently Asked Questions
How many lymphoma clinical trials are active in France?
There are currently 4 active clinical trials for lymphoma with sites in France, of which 4 are actively recruiting patients.
How can I join a lymphoma clinical trial in France?
To join a lymphoma clinical trial in France, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in France directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are lymphoma trials in France?
Active lymphoma trials in France span multiple phases. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: July 2026 · Data Methodology